These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 28412471)

  • 21. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N; Janga KY
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo.
    Wang P; Zhang L; Peng H; Li Y; Xiong J; Xu Z
    Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4802-8. PubMed ID: 24094190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
    Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
    Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats.
    Rawat MK; Jain A; Singh S
    J Pharm Sci; 2011 Jun; 100(6):2406-17. PubMed ID: 21491451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD.
    Liang J; Liu Y; Liu J; Li Z; Fan Q; Jiang Z; Yan F; Wang Z; Huang P; Feng N
    J Nanobiotechnology; 2018 Sep; 16(1):64. PubMed ID: 30176941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study to enhance the oral bioavailability of s-adenosyl-l-methionine (SAMe): SLN and SLN nanocomposite particles.
    Amasya G; Ergin AD; Erkan Cakirci O; Ozçelikay AT; Sezgin Bayindir Z; Yuksel N
    Chem Phys Lipids; 2021 Jul; 237():105086. PubMed ID: 33930379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cetyltrimethylammonium bromide-nanocrystalline cellulose (CTAB-NCC) based microemulsions for enhancement of topical delivery of curcumin.
    Zainuddin N; Ahmad I; Zulfakar MH; Kargarzadeh H; Ramli S
    Carbohydr Polym; 2021 Feb; 254():117401. PubMed ID: 33357890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization of solid lipid nanoparticles for enhanced delivery of curcumin in cocultures of HT29-MTX and Caco-2 cells.
    Guri A; Gülseren I; Corredig M
    Food Funct; 2013 Sep; 4(9):1410-9. PubMed ID: 23921424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells.
    Minafra L; Porcino N; Bravatà V; Gaglio D; Bonanomi M; Amore E; Cammarata FP; Russo G; Militello C; Savoca G; Baglio M; Abbate B; Iacoviello G; Evangelista G; Gilardi MC; Bondì ML; Forte GI
    Sci Rep; 2019 Jul; 9(1):11134. PubMed ID: 31366901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
    Talegaonkar S; Bhattacharyya A
    AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
    Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
    Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
    Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W
    Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
    Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
    Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
    Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
    J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation.
    Nooli M; Chella N; Kulhari H; Shastri NR; Sistla R
    Drug Dev Ind Pharm; 2017 Apr; 43(4):611-617. PubMed ID: 28005442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancing Curcumin Oral Bioavailability Through Nanoformulations.
    Ipar VS; Dsouza A; Devarajan PV
    Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):459-480. PubMed ID: 30771095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of curcumin loaded solid lipid nanoparticles for improved anticancer activity.
    Rompicharla SVK; Bhatt H; Shah A; Komanduri N; Vijayasarathy D; Ghosh B; Biswas S
    Chem Phys Lipids; 2017 Nov; 208():10-18. PubMed ID: 28842128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles.
    Lingling G; Yuan Z; Weigen L
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1325-33. PubMed ID: 26821124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physicochemical characterization of chitosan-hyaluronan-coated solid lipid nanoparticles for the targeted delivery of paclitaxel: a proof-of-concept study in breast cancer cells.
    Campos J; Varas-Godoy M; Haidar ZS
    Nanomedicine (Lond); 2017 Mar; 12(5):473-490. PubMed ID: 28181464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.